Reversible Neurological Adverse Reaction to Apixaban
Prescriptions for the novel oral anticoagulant factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) have equalled or exceeded those for vitamin K antagonists in many clinical settings requiring chronic anticoagulation, and those of injectable heparins for deep vein thrombosis prophylaxis. The auth...
Main Authors: | Eduardo Rodrigues Cernadas, Catarina Dionisio, Dalia Estevão, Leopoldina Vicente |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2021-04-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1739 |
Similar Items
-
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
by: Andrea Huppertz, et al.
Published: (2019-08-01) -
Apixaban
by: Gianluca Airoldi, et al.
Published: (2013-03-01) -
Apixaban linearity profile for hydrotropic solubilization
by: Santosh Karajgi, et al.
Published: (2020-01-01) -
Quick reference guide to apixaban
by: Hurst KV, et al.
Published: (2017-07-01) -
Rectus sheath hematoma associated with apixaban
by: Kulothungan Gunasekaran, et al.
Published: (2017-08-01)